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**Additional file 1.** Protocolo de ensayo clínico.
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Informed consent will be obtained before conducting any study-specific procedures.

Eligible subjects will be informed before the beginning of the study about the objectives and procedures, as well as the potential risks derived from his/her study participation.

The process of obtaining informed consent will be documented in the subject source documents.
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